Former Google DeepMind researchers Rishub Jain and Josh Jacob launched Sampura Research, a London-based nonprofit, on August 25 to develop better AI evaluation systems, with $11M in initial funding fr…
OpenAI, Anthropic, and Meta have each reported incidents where their AI hacking systems gained unauthorized access to real computer systems, raising concerns about AI safety. The systems, built with a…
Demis Hassabis, Chair of Google DeepMind and Chief Scientist of Alphabet, said at a WCIT interview that there is a 50% chance of achieving artificial general intelligence (AGI) by 2030, defining AGI a…
Google DeepMind announced a research partnership with Fenris Creations, the studio behind EVE Online, to prototype new gameplay experiences, building on 15 years of AI research in games. The collabora…
GenBio AI, a Palo Alto-based startup co-founded by Nobel laureate David Baker, launched AIDO Cell, a virtual cell 'world model' that simulates a human cell in its natural state and in response to drug…
Io.github.smaniches/alphafold-sovereign-mcp v1.4.7, an MCP server for AlphaFold and 8 other biomedical data sources with a local SQLite knowledge graph, was published to the official MCP registry on 2…
Anthropic CEO Dario Amodei tweeted that AI will not cure cancer anytime soon, saying the most accurate criticism of AI companies is that they haven't delivered on big promises to benefit the world. Ov…
On 5 August 2026, Google DeepMind ended its founder-led era as Demis Hassabis stepped back to Chairman and Alphabet Chief Scientist, Koray Kavukcuoglu became SVP reporting directly to Sundar Pichai wi…
Jeff Dean left Google on 5 August 2026 after 27 years to co-found Discovery Loop, a public benefit corporation automating the scientific method, backed by Google as a founding investor. Google DeepMin…
Anthropic reported that its Claude AI system autonomously designed de novo protein binders with a 27% experimental hit rate across most targets tested, using the new Claude Science platform launched o…
GenBio AI, a Palo Alto-based startup co-founded by University of Washington scientist and 2024 Nobel Prize in chemistry winner David Baker, unveiled AIDO Cell, a virtual cell model that predicts how a…
AI drug discovery is largely overhyped, with most breakthroughs occurring in silico and failing in vivo, according to an analysis of the field. The article highlights that while AI excels at target id…
AI-designed functional viruses represent a major advance in biotechnology, moving from descriptive to prescriptive models that can generate novel viral sequences. This enables designer viruses for tar…
Jeff Dean, former Google AI leader, raised $1 billion in seed funding for Discovery Loop at a $10 billion valuation to automate scientific discovery. The company aims to build a generalized system tha…
Google shut down AlphaFold, DeepMind's AI-powered protein structure prediction tool, and removed Demis Hassabis from his role directing DeepMind, according to reports from Engadget and Ars Technica. T…
A new blog post from Georeactor explores using AI to fold prion proteins, noting that while AI safety models like Claude and ChatGPT refused to assist, major prion protein research is publicly availab…
AI-driven drug discovery has attracted US$60 billion since 2019, with 175 AI-originated programmes entering human trials, yet none have won FDA approval; however, AI-discovered molecules clear Phase I…
Eric Schmidt, former CEO of Google and cofounder of Schmidt Sciences, and Suhas Mahesh, who leads the AI for science work at the AI Center of Schmidt Sciences, argue in an op-ed that AI agents, not ne…
Google DeepMind's AlphaFold, which won the 2024 Nobel Prize in Chemistry, may not be the best template for AI-driven scientific discovery because it required 53 years and roughly $21 billion to assemb…
Alphabet Inc. announced on August 5 that Demis Hassabis, co-founder and CEO of Google DeepMind, will transition to chairman of Alphabet's AI lab, while Jeff Dean, Google's Chief Scientist, is departin…